00514nas a2200181   4500000000100000000000100001008004100002100001400043700001400057700001200071700002100083700001300104700001400117245016600131300001400297490000700311022001400318       2017                            d1 aS. Holden1 aC. Morgan1 aQ. Qiao1 aS. Jenkins-Jones1 aE. Berni1 aC. Currie00aHealthcare resource utilization and related financial costs associated with glucose lowering with either exenatide or basal insulin: A retrospective cohort study  a1097-11050 v19  a1462-8902